TR199801797T2 - �ki kutuplu bozukluk tedavisi. - Google Patents

�ki kutuplu bozukluk tedavisi.

Info

Publication number
TR199801797T2
TR199801797T2 TR1998/01797T TR9801797T TR199801797T2 TR 199801797 T2 TR199801797 T2 TR 199801797T2 TR 1998/01797 T TR1998/01797 T TR 1998/01797T TR 9801797 T TR9801797 T TR 9801797T TR 199801797 T2 TR199801797 T2 TR 199801797T2
Authority
TR
Turkey
Prior art keywords
bipolar disorder
disorder treatment
treatment
zapin
seizure
Prior art date
Application number
TR1998/01797T
Other languages
English (en)
Turkish (tr)
Inventor
Merritt Beasley Charles
Dennis Tollefson Gary
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR199801797T2 publication Critical patent/TR199801797T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
TR1998/01797T 1996-03-11 1996-12-04 �ki kutuplu bozukluk tedavisi. TR199801797T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1315996P 1996-03-11 1996-03-11

Publications (1)

Publication Number Publication Date
TR199801797T2 true TR199801797T2 (xx) 1998-12-21

Family

ID=21758606

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01797T TR199801797T2 (xx) 1996-03-11 1996-12-04 �ki kutuplu bozukluk tedavisi.

Country Status (15)

Country Link
EP (1) EP0889725A4 (xx)
JP (1) JP2000506859A (xx)
KR (1) KR19990087713A (xx)
CN (1) CN1213966A (xx)
AU (1) AU734011B2 (xx)
BR (1) BR9612548A (xx)
CZ (1) CZ290298A3 (xx)
EA (1) EA000758B1 (xx)
HU (1) HUP9903679A3 (xx)
IL (1) IL126162A0 (xx)
NO (1) NO984189L (xx)
NZ (1) NZ326031A (xx)
PL (1) PL328925A1 (xx)
TR (1) TR199801797T2 (xx)
WO (1) WO1997033577A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960577B2 (en) 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
PL344331A1 (en) * 1998-05-22 2001-11-05 Lilly Co Eli Combination therapy for treatment of refractory depression
SK17492000A3 (sk) * 1998-05-29 2002-04-04 Eli Lilly And Company Liek na liečenie bipolárnych porúch a farmaceutický prostriedok
US6348455B1 (en) 1998-11-23 2002-02-19 Sepracor Inc. Desmetylolanzapine compositions and methods
CA2352611A1 (en) 1998-11-23 2000-06-02 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
AU757870B2 (en) * 1998-11-23 2003-03-06 Sepracor, Inc. Pharmaceutical compositions containing olanzapine-N-oxide
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use

Also Published As

Publication number Publication date
CN1213966A (zh) 1999-04-14
AU734011B2 (en) 2001-05-31
CZ290298A3 (cs) 1999-10-13
JP2000506859A (ja) 2000-06-06
IL126162A0 (en) 1999-05-09
EP0889725A1 (en) 1999-01-13
NZ326031A (en) 2001-05-25
BR9612548A (pt) 1999-07-20
KR19990087713A (ko) 1999-12-27
NO984189D0 (no) 1998-09-11
WO1997033577A1 (en) 1997-09-18
EA000758B1 (ru) 2000-04-24
EA199800819A1 (ru) 1999-02-25
EP0889725A4 (en) 2000-01-19
PL328925A1 (en) 1999-03-01
HUP9903679A3 (en) 2001-10-29
NO984189L (no) 1998-09-11
HUP9903679A2 (hu) 2000-04-28
AU1330797A (en) 1997-10-01

Similar Documents

Publication Publication Date Title
TR200000782T2 (tr) Resorsinol türevleri.
FI963070A (fi) Klooripyrimidiinivälituotteita
DE50114428D1 (de) Neue verwendung von kurzkettigen carbonsäuren
ES2186874T3 (es) Analogos de m-amidinofenilo como inhibidores del factor xa.
TR200101239T2 (tr) İkameli-2-fenilbenzimidazoller, üretimleri ve kullanımları
ES2179490T3 (es) Derivados de 1,2,4-triazolo(3,4-a)ftalazina sustituidos como ligandos de gaba alfa 5.
BR9806752A (pt) Ftalazinonas.
PT935465E (pt) Compostos novos de imidazole substituido
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
EA200100315A1 (ru) Простые тетрагидропиридовые эфиры
MA24643A1 (fr) Tetrahydro-naphtalenes substitues et composes analogues
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
DK0973544T3 (da) Immuntolerant prothrombinkomplekspræparat
DE50111331D1 (de) Neue verwendung von proteinhydrolysaten
DE60033918D1 (de) Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung
TR199801797T2 (xx) �ki kutuplu bozukluk tedavisi.
DE60025327D1 (de) 6-arylphenanthridine mit pde-iv hemmender wirkung
TR200002266T2 (tr) İnterlokin-6 üretimini canlandırıcı etkinliğe sahip bir bileşik içeren kozmetik kompozisyon.
ES2020953B3 (es) Complejos de tetrahidro-3,4-furanodiamina-n-n'platino.
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
PE20399A1 (es) Muteina ob